NM_005191.4:c.*214T>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005191.4(CD80):​c.*214T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.823 in 152,346 control chromosomes in the GnomAD database, including 51,707 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.82 ( 51558 hom., cov: 30)
Exomes 𝑓: 0.90 ( 149 hom. )

Consequence

CD80
NM_005191.4 3_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.638

Publications

21 publications found
Variant links:
Genes affected
CD80 (HGNC:1700): (CD80 molecule) The protein encoded by this gene is a membrane receptor that is activated by the binding of CD28 or CTLA-4. The activated protein induces T-cell proliferation and cytokine production. This protein can act as a receptor for adenovirus subgroup B and may play a role in lupus neuropathy. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005191.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 3-119525574-A-C is Benign according to our data. Variant chr3-119525574-A-C is described in ClinVar as Benign. ClinVar VariationId is 1224718.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.848 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005191.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD80
NM_005191.4
MANE Select
c.*214T>G
3_prime_UTR
Exon 7 of 7NP_005182.1P33681-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD80
ENST00000264246.8
TSL:1 MANE Select
c.*214T>G
3_prime_UTR
Exon 7 of 7ENSP00000264246.3P33681-1
CD80
ENST00000853991.1
c.*214T>G
3_prime_UTR
Exon 8 of 8ENSP00000524050.1
CD80
ENST00000853992.1
c.*214T>G
3_prime_UTR
Exon 6 of 6ENSP00000524051.1

Frequencies

GnomAD3 genomes
AF:
0.823
AC:
124984
AN:
151860
Hom.:
51516
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.829
Gnomad AMI
AF:
0.840
Gnomad AMR
AF:
0.778
Gnomad ASJ
AF:
0.729
Gnomad EAS
AF:
0.869
Gnomad SAS
AF:
0.862
Gnomad FIN
AF:
0.865
Gnomad MID
AF:
0.810
Gnomad NFE
AF:
0.821
Gnomad OTH
AF:
0.815
GnomAD4 exome
AF:
0.899
AC:
329
AN:
366
Hom.:
149
Cov.:
0
AF XY:
0.893
AC XY:
200
AN XY:
224
show subpopulations
African (AFR)
AF:
1.00
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.896
AC:
310
AN:
346
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.929
AC:
13
AN:
14
Other (OTH)
AF:
1.00
AC:
4
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.823
AC:
125085
AN:
151980
Hom.:
51558
Cov.:
30
AF XY:
0.825
AC XY:
61256
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.829
AC:
34386
AN:
41458
American (AMR)
AF:
0.778
AC:
11845
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.729
AC:
2531
AN:
3470
East Asian (EAS)
AF:
0.869
AC:
4495
AN:
5172
South Asian (SAS)
AF:
0.863
AC:
4164
AN:
4826
European-Finnish (FIN)
AF:
0.865
AC:
9122
AN:
10550
Middle Eastern (MID)
AF:
0.813
AC:
239
AN:
294
European-Non Finnish (NFE)
AF:
0.821
AC:
55824
AN:
67970
Other (OTH)
AF:
0.814
AC:
1715
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1148
2296
3444
4592
5740
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.816
Hom.:
199272
Bravo
AF:
0.815
Asia WGS
AF:
0.849
AC:
2952
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.4
DANN
Benign
0.50
PhyloP100
-0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7628626;
hg19: chr3-119244421;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.